We've documented the recent delay in Cronos' financials, and Medipharm's potential links to bulk sales and purchases of biomass. Our last structure on Medipharm Labs highlighted some margin slippa read more

We've documented the recent delay in Cronos' financials, and Medipharm's potential links to bulk sales and pu read more